Effects of Atypical Versus Conventional Antipsychotics on the Prevalence of Tardive Dyskinesia
This study has been completed.
Information provided by:
National Institute of Mental Health (NIMH)
First received: October 7, 2005
Last updated: February 22, 2006
Last verified: October 2005
This study will compare the effects of newer atypical antipsychotics with those of older conventional antipsychotics on the risk of tardive dyskinesia.
|Study Design:||Observational Model: Defined Population
Time Perspective: Longitudinal
|Official Title:||Prevalence of Tardive Dyskinesia Among Patients Treated With Atypical Vs Conventional Antipsychotic|
Further study details as provided by National Institute of Mental Health (NIMH):
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00237835
Sponsors and Collaborators
|Principal Investigator:||Scott W Woods, MD||Yale University|